A company shepherding research out of Mount Sinai Health System aims to establish a method for predicting a child’s chances of developing autism using information gleaned from a single piece of hair.

Healthcare startup LinusBio just raised a $16 million Series A funding round. The startup uses precision sequencing to detect autism and other complex diseases at birth. Check out the pitch deck ...

LinusBio has raised $16 million in series A financing from investors such as GreatPoint Ventures and Bow Capital. The company will use the funds to develop and expand its exposome sequencing ...

Please provide your email address to receive an email when new articles are posted on . LinusBio announced it has raised over $16 million in Series A funding to deliver technology that combines ...

The discovery holds promise to provide drug developers with an objective measure for clinical trials, help identify new pathways, and enable earlier identification LinusBio, a leader in exposomic ...

The MarketWatch News Department was not involved in the creation of this content. The discovery holds promise to provide drug developers with an objective measure for clinical trials, help identify ...